163 related articles for article (PubMed ID: 22324943)
1. Vitamin D levels: its relationship to bone mineral density response and disease activity in premenopausal Malaysian systemic lupus erythematosus patients on corticosteroids.
Yeap SS; Othman AZ; Zain AA; Chan SP
Int J Rheum Dis; 2012 Feb; 15(1):17-24. PubMed ID: 22324943
[TBL] [Abstract][Full Text] [Related]
2. A comparison of calcium, calcitriol, and alendronate in corticosteroid-treated premenopausal patients with systemic lupus erythematosus.
Yeap SS; Fauzi AR; Kong NC; Halim AG; Soehardy Z; Rahimah I; Chow SK; Goh EM
J Rheumatol; 2008 Dec; 35(12):2344-7. PubMed ID: 19004038
[TBL] [Abstract][Full Text] [Related]
3. Influences on bone mineral density in Malaysian premenopausal systemic lupus erythematosus patients on corticosteroids.
Yeap SS; Fauzi AR; Kong NC; Halim AG; Soehardy Z; Rahimah S; Chow SK; Goh EM
Lupus; 2009 Feb; 18(2):178-81. PubMed ID: 19151123
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D status and bone mineral density changes during alendronate treatment in postmenopausal osteoporosis.
Roux C; Binkley N; Boonen S; Kiel DP; Ralston SH; Reginster JY; Pong A; Rosenberg E; Santora A;
Calcif Tissue Int; 2014 Feb; 94(2):153-7. PubMed ID: 23912950
[TBL] [Abstract][Full Text] [Related]
5. Effect of calcitriol on bone mineral density in premenopausal Chinese women taking chronic steroid therapy. A randomized, double blind, placebo controlled study.
Lambrinoudaki I; Chan DT; Lau CS; Wong RW; Yeung SS; Kung AW
J Rheumatol; 2000 Jul; 27(7):1759-65. PubMed ID: 10914864
[TBL] [Abstract][Full Text] [Related]
6. Loss of bone mineral density in Chinese pre-menopausal women with systemic lupus erythematosus treated with corticosteroids.
Li EK; Tam LS; Young RP; Ko GT; Li M; Lau EM
Br J Rheumatol; 1998 Apr; 37(4):405-10. PubMed ID: 9619891
[TBL] [Abstract][Full Text] [Related]
7. Uncoupled bone remodeling is characteristic of bone damage in premenopausal women with new-onset systemic lupus erythematosus.
Zhu L; Zhang J; Wang J; Lv X; Pu D; Wang Y; Men Q; He L
Lupus; 2021 Jun; 30(7):1116-1123. PubMed ID: 33832361
[TBL] [Abstract][Full Text] [Related]
8. Eldecalcitol increases bone mineral density in Chinese osteoporotic patients without vitamin D or calcium supplementation.
Jiang Y; Tang H; Ma X; Cheng Q; Lin H; Jin X; Zhang Z; Yu W; He S; Kobayashi T; Uehara S; Matsumoto T; Xia W
J Bone Miner Metab; 2019 Nov; 37(6):1036-1047. PubMed ID: 31087185
[TBL] [Abstract][Full Text] [Related]
9. Bone mineral density reduction in adolescents with systemic erythematosus lupus: association with lack of vitamin D supplementation.
Caetano M; Terreri MT; Ortiz T; Pinheiro M; Souza F; Sarni R
Clin Rheumatol; 2015 Dec; 34(12):2065-70. PubMed ID: 26227163
[TBL] [Abstract][Full Text] [Related]
10. Dietary calcium and bone mineral density in premenopausal women with systemic lupus erythematosus.
Chong HC; Chee SS; Goh EM; Chow SK; Yeap SS
Clin Rheumatol; 2007 Feb; 26(2):182-5. PubMed ID: 16565892
[TBL] [Abstract][Full Text] [Related]
11. Bone mineral density changes in women with systemic lupus erythematosus.
Boyanov M; Robeva R; Popivanov P
Clin Rheumatol; 2003 Oct; 22(4-5):318-23. PubMed ID: 14579164
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness and safety of vitamin D in relation to bone health.
Cranney A; Horsley T; O'Donnell S; Weiler H; Puil L; Ooi D; Atkinson S; Ward L; Moher D; Hanley D; Fang M; Yazdi F; Garritty C; Sampson M; Barrowman N; Tsertsvadze A; Mamaladze V
Evid Rep Technol Assess (Full Rep); 2007 Aug; (158):1-235. PubMed ID: 18088161
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and predictors of low bone density and fragility fractures in women with systemic lupus erythematosus in a Mediterranean region.
Salman-Monte TC; Torrente-Segarra V; Muñoz-Ortego J; Mojal S; Carbonell-Abelló J
Rheumatol Int; 2015 Mar; 35(3):509-15. PubMed ID: 25030324
[TBL] [Abstract][Full Text] [Related]
14. Are oral bisphosphonates effective in improving lumbar bone mineral density in breast cancer survivors with osteopenia or osteoporosis?
Sawka AM; Ioannidis G; Papaioannou A; Thabane L; Olszynski WP; Brown JP; Hanley DA; Murray TM; Josse RG; Sebaldt RJ; Petrie A; Tenenhouse A; Goldsmith CH; Boulos P; Kouroukis T; Adachi JD
J Obstet Gynaecol Can; 2005 Aug; 27(8):759-64. PubMed ID: 16287007
[TBL] [Abstract][Full Text] [Related]
15. Secondary hyperparathyroidism due to hypovitaminosis D affects bone mineral density response to alendronate in elderly women with osteoporosis: a randomized controlled trial.
Barone A; Giusti A; Pioli G; Girasole G; Razzano M; Pizzonia M; Palummeri E; Bianchi G
J Am Geriatr Soc; 2007 May; 55(5):752-7. PubMed ID: 17493196
[TBL] [Abstract][Full Text] [Related]
16. Increase in bone mass after correction of vitamin D insufficiency in bisphosphonate-treated patients.
Geller JL; Hu B; Reed S; Mirocha J; Adams JS
Endocr Pract; 2008 Apr; 14(3):293-7. PubMed ID: 18463035
[TBL] [Abstract][Full Text] [Related]
17. Changes in blood and urinary cadmium levels and bone mineral density according to osteoporosis medication in individuals with an increased cadmium body burden.
Eom SY; Yim DH; Hong SM; Kim YD; Kim H; Choi BS; Park JD; Park CH; Kim GB; Yu SD
Hum Exp Toxicol; 2018 Apr; 37(4):350-357. PubMed ID: 28441892
[TBL] [Abstract][Full Text] [Related]
18. [Bone density and 25-OH vitamin D serum level in patients with systemic lupus erythematosus].
Becker A; Fischer R; Schneider M
Z Rheumatol; 2001 Oct; 60(5):352-8. PubMed ID: 11759235
[TBL] [Abstract][Full Text] [Related]
19. Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV.
McComsey GA; Kendall MA; Tebas P; Swindells S; Hogg E; Alston-Smith B; Suckow C; Gopalakrishnan G; Benson C; Wohl DA
AIDS; 2007 Nov; 21(18):2473-82. PubMed ID: 18025884
[TBL] [Abstract][Full Text] [Related]
20. Determinants of bone mass in systemic lupus erythematosus: a cross sectional study on premenopausal women.
Sinigaglia L; Varenna M; Binelli L; Zucchi F; Ghiringhella D; Gallazzi M; Limonta M; Zeni S; Fantini F
J Rheumatol; 1999 Jun; 26(6):1280-4. PubMed ID: 10381043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
